-
Predicting Major Bleeding During Extended Anticoagulation
2026-09-21
This prospective multinational cohort study evaluated bleeding-risk prediction in patients with unprovoked or weakly provoked venous thromboembolism receiving extended anticoagulation. Modified ACCP, VTE-BLEED, and HAS-BLED scores identified higher-risk patients, while the simpler CHAP model used continuous creatinine, hemoglobin, age, and antiplatelet-use variables and showed comparable discrimination, although external validation remains necessary.
-
Ranolazine: A Mechanistic Roadmap for Translation
2026-09-21
Ranolazine offers a useful translational model for connecting ion handling, myocardial relaxation, and metabolic efficiency. By pairing its cardiac mechanism with lessons from HBV–TBK1 research, this article presents a rigorous framework for designing cardiac ischemia and liver metabolism assays without overstating cross-domain evidence.
-
SETD7 Depletion Drives White Fat Browning in Obesity
2026-09-20
A 2026 Cell Death & Differentiation study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis. Genetic SETD7 depletion enhanced beige-fat activation through an Adcy7–Sirt1–CREB1 pathway, increased energy expenditure, and improved resistance to high-fat-diet-induced metabolic dysfunction in mice.
-
X-Gal Workflows for Cloning and Reporter Assays
2026-09-19
Build more reliable blue-white colony screening workflows with X-Gal, from stock preparation and plate design to clone confirmation. The same chromogenic chemistry can also support engineered β-galactosidase reporter studies, provided its qualitative readout is interpreted alongside molecular and transcriptomic assays.
-
Reserpine (N1867): Lab Workflow Guide
2026-09-19
Reserpine (SKU N1867) provides a characterized research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide focuses on preparation, storage, and quality control; the material is for research use only and should not be used for diagnostic, therapeutic, clinical, or veterinary applications.
-
BIBR 1532: Selective Telomerase Inhibitor Guide
2026-09-18
BIBR 1532 is a non-nucleosidic telomerase inhibitor that targets the hTERT reverse transcriptase component and is reported to inhibit human telomerase at 93 nM. Its research value lies in linking telomerase inhibition with telomere shortening, cancer cell proliferation inhibition, and apoptosis-associated signaling in leukemia models.
-
CFDA SE Cell Tracer Kit: Practical Guide
2026-09-17
The CFDA SE Cell Tracer Kit provides persistent fluorescent labeling for multi-day cell tracking, cell proliferation studies, and cell lineage tracing. It is suited to covalent, long-term marking but not to reversible, short-term labeling or workflows requiring rapid dye clearance.
-
Stattic Workflows for STAT3-Driven Assays
2026-09-17
Stattic is a mechanism-focused STAT3 inhibitor for connecting pathway suppression with apoptosis, transcriptional changes, and radiation response. This practical guide covers dose planning, orthogonal validation, cross-domain interpretation, and troubleshooting for HNSCC and exploratory keratinocyte assays.
-
CHIR-99021 for Wnt-Driven Organoid Workflows
2026-09-16
Use CHIR-99021 (CT99021) to create a controlled GSK-3 inhibition arm for stem-cell, organoid, and differentiation experiments. This guide connects pathway activation with suspension human intestinal organoid design, practical dosing, assay controls, and troubleshooting.
-
Sunitinib Workflows for RTK and Angiogenesis Research
2026-09-16
Sunitinib enables integrated studies of receptor tyrosine kinase signaling, tumor-cell survival, cell-cycle control, and angiogenesis. This workflow also translates recent TRIB3–SLC7A11/GPX4 findings into practical assays for investigating drug sensitivity and ferroptosis in clear cell renal cell carcinoma.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-15
Cy5 NHS ester(Et) is an amine-reactive fluorescent dye for covalently tagging proteins, peptides, and other biomolecules in workflows such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is suitable for aqueous or DMSO-assisted preparation but should not be used in ethanol-based protocols or retained as a long-term working solution.
-
Chloroquine Diphosphate in Ferroptosis Translation
2026-09-15
A translational framework for using Chloroquine diphosphate as a mechanistic autophagy and cell-cycle perturbation alongside the DGLA–ACSL4 ferroptosis axis in acute myeloid leukemia research.
-
Saracatinib (AZD0530): From Src Biology to Translation
2026-09-14
Saracatinib (AZD0530) offers a mechanism-led framework for studying Src/Abl signaling across cancer models, while carefully bounded analysis of Reelin–SFK biology reveals how pathway context can guide translational assay design.
-
SORL1 Deficiency Reshapes Neuronal and Microglial ELN
2026-09-14
Mishra, Jayadev, and Young synthesize evidence that SORL1 deficiency disrupts different compartments of the endo-lysosomal network in human neurons and microglia. Their cell-type-specific interpretation highlights why human induced pluripotent stem cell models are valuable for connecting Alzheimer’s disease risk genes with therapeutic mechanisms.
-
Dacomitinib (PF-00299804) Assay Guide
2026-09-13
A scenario-based guide to using Dacomitinib (PF-00299804), SKU A8319, in viability, proliferation, cytotoxicity, and exploratory ferroptosis studies. It connects reported pan-HER potency with practical controls, formulation handling, interpretation limits, and vendor-selection considerations.